1. Counterfeit Viagra and Cialis seized from stores in Toronto

   News item 23 March 2024 Pages: 1 - 1

2. Dabigatran: risk of acute kidney injury

   Review 23 March 2024 Pages: 2 - 2

3. Many drugs increase methotrexate plasma concentrations

   News item 23 March 2024 Pages: 3 - 3

4. MARC December 2023 meeting highlights

   News item 23 March 2024 Pages: 4 - 4

5. mRNA COVID-19 vaccines not linked to postmenopausal bleeding

   News item 23 March 2024 Pages: 5 - 5

6. Nivolumab-related capillary leak syndrome

   News item 23 March 2024 Pages: 6 - 6

7. Prescription drug-related psychiatric adverse effects

   News item 23 March 2024 Pages: 7 - 7

8. Preventing poisoning in the home: medicine safety reminder

   News item 23 March 2024 Pages: 8 - 8

9. Biological therapy-related ADRs in patients with severe asthma

   Clinical study 23 March 2024 Pages: 9 - 9

10. Concurrent use of opioids and skeletal muscle relaxants: assessing comparative risk of injury due to oversedation

    Clinical study 23 March 2024 Pages: 10 - 10

11. Genetic variants contribute to drug-induced interstitial lung diseases

    Clinical study 23 March 2024 Pages: 11 - 11

12. VEGF inhibitors increase risk of aortic aneurysm, aortic dissection

    Clinical study 23 March 2024 Pages: 12 - 12

13. Other adverse reaction research

    News item 23 March 2024 Pages: 13 - 13

14. Abemaciclib/Anastrozole

    Case report 23 March 2024 Pages: 14 - 14

15. Aciclovir/ganciclovir/tacrolimus

    Case report 23 March 2024 Pages: 15 - 15

16. Ad26.COV2-S/elasomeran/tozinameran

    Case report 23 March 2024 Pages: 16 - 16

17. Ad26.COV2-S/tozinameran

    Case report 23 March 2024 Pages: 17 - 17

18. Adenosine/diltiazem/nitroglycerin

    Case report 23 March 2024 Pages: 18 - 18

19. Adenosine/tizanidine

    Case report 23 March 2024 Pages: 19 - 19

20. Aesculus-hippocastanum

    Case report 23 March 2024 Pages: 20 - 20

21. Afatinib/Ramucirumab

    Case report 23 March 2024 Pages: 21 - 21

22. Alendronic-acid

    Case report 23 March 2024 Pages: 22 - 22

23. Allopurinol/Immune-globulin

    Case report 23 March 2024 Pages: 23 - 23

24. Ambrisentan/Thiamazole

    Case report 23 March 2024 Pages: 24 - 24

25. Amiodarone

    Case report 23 March 2024 Pages: 25 - 25

26. Amiodarone/Antithrombotics

    Case report 23 March 2024 Pages: 26 - 26

27. Amiodarone/glimepiride/vildagliptin

    Case report 23 March 2024 Pages: 27 - 27

28. Amiodarone/prednisone

    Case report 23 March 2024 Pages: 28 - 28

29. Amoxicillin/epinephrine

    Case report 23 March 2024 Pages: 29 - 29

30. Anakinra/tocilizumab

    Case report 23 March 2024 Pages: 30 - 30

31. Analgesics/antihyperglycaemics

    Case report 23 March 2024 Pages: 31 - 31

32. Antibacterials

    Case report 23 March 2024 Pages: 32 - 32

33. Antibacterials

    Case report 23 March 2024 Pages: 33 - 33

34. Antibacterials

    Case report 23 March 2024 Pages: 34 - 34

35. Antiepileptic-drugs

    Case report 23 March 2024 Pages: 35 - 35

36. Antiepileptic-drugs/Asparagine

    Case report 23 March 2024 Pages: 36 - 36

37. Antiepileptics

    Case report 23 March 2024 Pages: 37 - 37

38. Antihypertensives/proxymetacaine/ranibizumab

    Case report 23 March 2024 Pages: 38 - 38

39. Antineoplastics

    Case report 23 March 2024 Pages: 39 - 39

40. Antineoplastics

    Case report 23 March 2024 Pages: 40 - 40

41. Antineoplastics

    Case report 23 March 2024 Pages: 41 - 41

42. Antineoplastics

    Case report 23 March 2024 Pages: 42 - 42

43. Antineoplastics

    Case report 23 March 2024 Pages: 43 - 43

44. Antineoplastics

    Case report 23 March 2024 Pages: 44 - 44

45. Antineoplastics

    Case report 23 March 2024 Pages: 45 - 45

46. Antineoplastics

    Case report 23 March 2024 Pages: 46 - 46

47. Antineoplastics

    Case report 23 March 2024 Pages: 47 - 47

48. Antineoplastics

    Case report 23 March 2024 Pages: 48 - 48

49. Antineoplastics

    Case report 23 March 2024 Pages: 49 - 49

50. Antineoplastics/antivirals/steroids

    Case report 23 March 2024 Pages: 50 - 50